STEM CELLS

LOOK AT THE BLOG Two key challenges in stem cell use: ethics and safety. Learn risks, regulations, and best practices in our web story.

WHAT ARE STEM CELLS? WHY IS THE POTENTIAL SO BIG?

Stem cells can turn into multiple cell types, placing them at the heart of regenerative medicine. A projected $270B market by 2028 highlights promising applications across many diseases.

TWO TYPES: PLURIPOTENT AND MULTIPOTENT

Pluripotent cells can become any cell type; multipotent cells are lineage limited. This distinction shapes therapy targets and clinical strategies.

FROM EMBRYOS TO ADULT TISSUE

TODAY’S APPLICATIONS: BLOOD, SKIN, CORNEA

EMERGING FIELDS: HEART, NEURO, DIABETES

ISSUE 1: ETHICAL DEBATE AND CONSENT

ISSUE 2: SAFETY AND CLINICAL RISKS

BEWARE: UNPROVEN TREATMENTS

THE FUTURE: SAFE, EFFECTIVE, PERSONALIZED

Stories

[{"selector":"#anim-96ac006e-4dd5-4ac4-81d7-188bb1010676","keyframes":{"opacity":[0,1]},"delay":100,"duration":800,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b339e0ec-6e19-4ff1-a66f-f3a0d7909794","keyframes":{"transform":["translate3d(-118.35205%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":800,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c9d7238c-a697-411e-928c-41fc8077e81f","keyframes":{"opacity":[0,1]},"delay":0,"duration":800,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2b966b00-01a1-41ed-8f36-33bad080b6c4","keyframes":{"transform":["translate3d(-123.52942%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":800,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ddff3356-e94b-4e25-a07f-06957715a6a3","keyframes":{"opacity":[0,1]},"delay":200,"duration":3000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2ca6e9b6-75e7-4876-951b-5fd5b9fc651f","keyframes":{"opacity":[0,1]},"delay":300,"duration":1200,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-65a562d8-1255-46d5-a044-5a7485adbfb1","keyframes":{"opacity":[0,1]},"delay":300,"duration":1200,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-512af241-fba9-4314-bcf9-64ef14abd93b","keyframes":{"opacity":[0,1]},"delay":300,"duration":1200,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f9715920-7f99-4905-bf87-2fce8aace70d","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-dce1e6f9-28bf-4382-9a8c-d776e860a41b","keyframes":{"opacity":[0,1]},"delay":300,"duration":3000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-44b265d8-c294-4e23-9549-8e863fab63f6","keyframes":{"opacity":[0,1]},"delay":400,"duration":1200,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0a70c870-1d14-4d0b-be2b-bbe8eba6ba90","keyframes":{"opacity":[0,1]},"delay":400,"duration":1200,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-bed4a07b-899d-48f3-ba17-5ce8ed60f201","keyframes":{"opacity":[0,1]},"delay":400,"duration":1200,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-136445ed-9b48-466b-b652-67a55a6b02c9","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ed062172-3990-4630-b650-182510877f19","keyframes":{"opacity":[0,1]},"delay":400,"duration":3000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-786d4b8a-fbe6-4d9d-8f44-097783883f7d","keyframes":{"opacity":[0,1]},"delay":500,"duration":1200,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-eaa1c380-1291-4973-88fa-00145df0f993","keyframes":{"opacity":[0,1]},"delay":500,"duration":1200,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0f39f39e-0e13-49c9-b201-39829e14d7bd","keyframes":{"opacity":[0,1]},"delay":500,"duration":1200,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5e1d1a7e-a2c2-4d14-809c-174b30eef330","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] See More See More See More

STEM CELLS

TWO IMPORTANT ISSUES IN USING

WHAT ARE STEM CELLS? WHY IS THE POTENTIAL SO BIG?

TWO TYPES: PLURIPOTENT AND MULTIPOTENT

FROM EMBRYOS TO ADULT TISSUE

Embryonic stem cells offer broad potential but raise ethical debates; adult stem cells (bone marrow, adipose, blood) are more acceptable ethically yet have limited plasticity.

TODAY’S APPLICATIONS: BLOOD, SKIN, CORNEA

Bone marrow transplant, skin grafting for severe burns, and corneal repair are established stem cell uses with proven effectiveness.

EMERGING FIELDS: HEART, NEURO, DIABETES

Research advances in cardiac repair, neurodegeneration (Parkinson’s/MS), and pancreatic regeneration for diabetes; clinical evidence is expanding.

ISSUE 1: ETHICAL DEBATE AND CONSENT

Embryo moral status, ownership of biological materials, and informed consent are core ethical axes. Transparency and protection of rights are essential.

ISSUE 2: SAFETY AND CLINICAL RISKS

Risks include infection, immune rejection, misdifferentiation, and tumor formation. Long term effects and genetic stability require close monitoring.

BEWARE: UNPROVEN TREATMENTS

“Stem cell tourism” and exaggerated claims can exploit patients. Don’t proceed without clinical evidence, regulatory oversight, and specialist advice.

THE FUTURE: SAFE, EFFECTIVE, PERSONALIZED

Advanced differentiation, better HLA matching, targeted immunosuppression, and novel delivery methods are paving the way to safer, more effective, personalized therapies.

Stories

More

WORRIED ABOUT CANCER?

WHAT IS THE BIGGEST CAUSE OF CANCER

THE HARDEST CANCERS TO DETECT